Ricochet is the best place on the internet to discuss the issues of the day, either through commenting on posts or writing your own for our active and dynamic community in a fully moderated environment. In addition, the Ricochet Audio Network offers over 50 original podcasts with new episodes released every day.
The Wall Street Journal Sets Axios Straight on What Delayed the Development of Molnupiravir
Pharmaceutical manufacturer Merck announced today the company is seeking FDA emergency-use authorization for its experimental antiviral treatment for COVID-19, molnupiravir.
On Oct. 1, Merck released a statement that said, “At the interim analysis, molnupiravir reduced the risk of hospitalization or death by approximately 50%; 7.3% of patients who received molnupiravir were either hospitalized or died through Day 29 following randomization, compared with 14.1% of placebo-treated patients.”
Once upon a time, political priors were no match for a great comedy – funny was funny. Today many great jokes elicit an anxious over-the-shoulder glance to ensure that the culture’s tastemakers – or your firm’s 22-year-old social media intern – don’t disapprove. Rolling with it is a thing of the past.
I noted a week ago that White House Press Secretary Kayleigh McEnany had opened two weeks in a row with a remembrance of all the black lives that do not matter to the Marxists running Black Lives Matter, the DNC, and their media jackals. I showed that the press corps completely ignored and buried that news in their half-hour hate. I concluded that Kayleigh McEnany should continue the demonstration of real care for all black lives this Monday and then slam the trap shut when the leftists again ignore black lives lost on our city streets. She did, and it was a thing of beauty, “all black lives matter:”
This screenshot is from The New York Times website on April 25, 2019. It was nestled among other stories. So, how do you think this lede got by the brain of the person who posted it alongside this photograph? Really?
